Title :
Vaporization, photoacoustic and acoustic characterization of PLGA/PFH particles loaded with optically absorbing materials
Author :
Yang Sun ; Chengcheng Niu ; Yuanyi Zheng ; Haitao Ran ; Zhigang Wang ; Wang, Y.J. ; Strohm, Eric M. ; Kolios, Michael C.
Author_Institution :
Inst. of Ultrasound Imaging, Chongqing Med. Univ., Chongqing, China
Abstract :
Poly (lactide-co-glycolic acid) (PLGA) is an FDA approved biocompatible and biodegradable material that is commonly used in implantation and drug delivery applications. It can be used as a carrier for various chemotherapeutic drugs, imaging agents and targeting moieties. Perfluorocarbon (PFC) liquids have been used in various biomedical applications, and can be activated (i.e. the liquid core converted to gas) via laser irradiation through the incorporation of optically absorbing nanoparticles or dyes within the emulsions. PLGA particles were synthesized with nanoparticles (gold or iron oxide) or dyes (DiI or rhodamine) within the PLGA shell and perfluorohexane (PFH) in the core. The photoacoustic signals and vaporization threshold of individual micron-sized particles were examined to optimize the dye and nanoparticle combination. The PLGA/PFH particles containing gold nanoparticles and DiI had the lowest vaporization threshold, with each particle consistently requiring less than 100 mJ/cm2 for vaporization. The effects of vaporization were then tested in cell culture. The particles were internalized by MDA breast cancer cells, and then irradiated with a laser. Once the particle was vaporized, a bubble formed within the cell which destroyed the cell. This work presents a first study of using a solid-shell PLGA particle encapsulating PFH liquid as a theragnostic agent.
Keywords :
biomedical materials; bubbles; cancer; cellular effects of radiation; drug delivery systems; dyes; emulsions; encapsulation; gold; iron compounds; laser applications in medicine; nanomedicine; nanoparticles; patient diagnosis; photoacoustic effect; polymers; ultrasonic therapy; vaporisation; Au; DiI; FDA approved biocompatible material; Fe2O3; MDA breast cancer cells; PFC; PFH liquid encapsulation; PLGA shell; PLGA/PFH particles; biodegradable material; biomedical applications; bubble formation; cell culture; chemotherapeutic drugs; drug delivery application; drug delivery applications; dye combination; emulsions; gold nanoparticles; imaging agents; implantation; iron oxide; laser irradiation; liquid core; micron-sized particles; nanoparticle combination; optically absorbing material; optically absorbing nanoparticle incorporation; perfluorocarbon liquids; perfluorohexane; photoacoustic characterization; photoacoustic signal threshold; poly (lactide-co-glycolic acid); rhodamine; solid-shell PLGA particle; targeting moieties; theragnostic agent; vaporization threshold; Acoustics; Atmospheric measurements; Biomedical optical imaging; Gold; Nanoparticles; Optical imaging; Particle measurements; PLGA particles; Photoacoustics; contrast agents; theragnostic agents;
Conference_Titel :
Ultrasonics Symposium (IUS), 2013 IEEE International
Conference_Location :
Prague
Print_ISBN :
978-1-4673-5684-8
DOI :
10.1109/ULTSYM.2013.0034